Dr. Pascale Diesel has 18 years of pharmaceutical and biotech experience in global development, marketing, planning and business development. She has worked across various therapy areas, mostly in specialty care. In her 10 years of strategic consulting, Pascale has specialized in decision optimization and commercial transactional support, working for pharma and biotech globally. She is an expert in product strategy and valuation, market and strategic assessment, product lifecycle and portfolio management, across geographies.
Prior to joining CRA, Pascale was Principal, Strategy and Portfolio Analysis, EMEA at QuintilesIMS, now doing business as IQVIA, concentrating on commercial due diligence (sell- and buy-side), sustainable growth and geographic expansion.
Previously she was Director of Strategic Market Development for Cambridge Antibody Technology, a biotechnology firm focused on antibody therapeutics. At Roche, Pascale was International Medical Manager, preparing and launching an orphan drug.
Doctorate, Pharmacy, Université Claude Bernard Lyon 1
Business Studies, San Jose State University, CA